Welling Health vs HealthRX
Thirty-five dollars apart, and only one states what happens at a higher dose.
Welling Health
Editorial
$130/mo
Compounded semaglutide at $94 and compounded tirzepatide at $135, both described as direct cost and both re-read in September 2026 from $190 and $275. A $36 monthly Rx track membership is required to be prescribed and sits outside each figure, putting one month at $130 or $171.
Pick it for: Buyers who want the lower opening figure across fifty states
HealthRX
Editorial
$165/mo
A four-rung term ladder with the renewal figure printed beside it: compounded semaglutide is $133 on three months and $99 on twelve, renewing month to month at $165. Compounded tirzepatide runs $209 and $179 on the same terms and renews at $214. The site states the price is the same at every dose.
Pick it for: Buyers who want the rate pinned before the dose moves
Our verdict
HealthRx states a flat rate at $165; Welling Health opens lower at $130 and publishes no dose behavior. The cheaper opener is the less certain one.
What actually separates them
Welling Health and HealthRX state different things about published price. Everything else they publish, they publish the same way.
HealthRX costs $35 more than Welling Health — 27% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,560 at Welling Health against $1,980 at HealthRX — a difference of $420.
| Welling Health | HealthRX | |
|---|---|---|
| Published price | $130/mo | $165/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.